… stress and RA symptoms may be occurring not only at a daily level, but that stressors may …
on awakening, at 7 randomly chosen points throughout the day, and at the end of the day. …

… data at random … at all stressful”) to 100 (“as stressful as you can imagine”). Additionally,
subjects were asked to make ratings upon awakening in the morning and before retiring at …

… ≥ 3 months at doses of 25 mg twice weekly or 50 mg weekly, at least 4 infusions of ≥ 3
mg/kg infliximab, or 40 mg of adalimumab every other week for ≥ 3 months). Disease-modifying …

… RAPID3 distinguishes active from control treatments at levels similar to the DAS28 and …
Appendix A, available in the online version of this article at http://www3.interscience.wiley. com/…

… First, we looked at patients who completed at least 7 of the 10 PCST sessions (82% of the
randomized PCST patients), and second, we looked at patients who completed at least 50% of …

… Sponsorships or competing interests that may be relevant to content are disclosed at the …
Missing Completely at Random or Missing at Random . The significance level was set at 0.05, …

… for a training session at our laboratory and two days of EMA. … kept in a freezer at our laboratory
before being analyzed. … Saliva samples were spun at 3,000 revolutions per minute for 5 …

… Exclusion criteria were nonfluency in English, no access to a VCR at home, inability to write
for 20 min at a time, not remaining in the geographic region for the next 4 to 6 months, being …

… In short-term experiments, a 50% effective dose (ED) was obtained at 5–10 pg/ml, with
maximum viral inhibition at 20 pg/ml. At these concentrations there was almost no direct cytotoxic …

• To investigate outcome and pathophysiology of central nervous system (CNS) systemic lupus
erythematosus (SLE), we prospectively codified all cases of CNS SLE. Eighty-two events …